We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Amazon, Roche, GE Aerospace, Canterbury Park and NVE
Read MoreHide Full Article
For Immediate Releases
Chicago, IL – September 9, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN - Free Report) , Roche Holding AG (RHHBY - Free Report) , GE Aerospace (GE - Free Report) , Canterbury Park Holding Corp. (CPHC - Free Report) and NVE Corp. (NVEC - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Amazon.com, Roche and GE Aerospace
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Roche Holding AG and GE Aerospace, as well as two micro-cap stocks Canterbury Park Holding Corp. and NVE Corp. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Amazon.com shares have lost ground lately, along with the rest of its Magnificent 7 peers and other megacap Tech operators, but they have still been strong performers this year (up +13.7% vs. +15.3% for the S&P 500 index. The company is gaining on solid Prime momentum owing to ultrafast delivery services and strong content portfolio. Strengthening relationships with third-party sellers is a positive.
Amazon.com’s expanding global presence and solid momentum among the small and medium businesses, remain a plus. Growing adoption of AWS is aiding Amazon’s cloud dominance. Deepening focus on generative AI is a major plus. Also, improving Alexa skills along with robust smart home products offerings are tailwinds. Growing capabilities in grocery, pharmacy, healthcare and autonomous driving are other positives.
However, macroeconomic challenges remain headwinds. Amazon issued weak third-quarter 2024 revenue guidance due to the changing shopping pattern of consumers, which is a negative.
Shares of Roche have outperformed the Zacks Large Cap Pharmaceuticals industry over the past three months (+22.0% vs. +4.1%). The company's performance in the second quarter and the first half of 2024 was impressive because of the high demand for its drugs and tests.
The second quarter saw an acceleration in growth as total sales were no longer affected by the decline in COVID-19 sales, resulting in very strong sales growth. Consequently, Roche raised its earnings outlook for the full year. Vabysmo, Ocrevus, Evrysdi and Polivy boost growth. Vabysmo has put up a stellar performance against Eylea.
Meanwhile, Roche is also looking to diversify and make inroads in the lucrative obesity market in the wake of declining sales from legacy drugs due to competition from biosimilars. The company’s efforts to develop new drugs are encouraging. The base diagnostics business is also performing well.
Shares of GE Aerospace have outperformed the Zacks Transportation - Airline industry over the past six months (+25.1% vs. +7.7%). The company has been witnessing strength in its businesses, driven by robust demand for commercial engines, propulsion and additive technologies.
Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company. GE Aerospace remains committed to making investments to boost growth and provide better services to its customers.
Its portfolio-reshaping actions are likely to unlock values for its shareholders. Its shareholder-friendly policies are encouraging. For 2024, it expects organic revenues to grow in the high-single-digit range from the year-ago level. However, it has been dealing with high costs and expenses related to projects and restructuring activities.
Canterbury Park’s shares have underperformed the Zacks Gaming industry over the year-to-date period (-0.6% vs. +6.8%). This microcap company with market capitalization of $100.78 million offers significant long-term revenue potential through diversified projects like an amphitheater, Winners Circle and residential units, driving growth beyond traditional gaming.
Financially stable with $24 million in cash and short-term investments, Canterbury Park can fund growth without debt. Improved EBITDA margins and diversified revenue streams, including pari-mutuel wagering and event hosting, support CPHC’s earnings stability. The company’s vision of a regional destination is progressing, with leasing success indicating solid demand.
However, risks include a 93.6% drop in second-quarter 2024 net income due to a non-recurring gain in 2023, weak casino revenues and substantial losses from equity investments. Increased competition from nearby casinos could impact market share and profitability.
Shares of NVE have gained +0.5% over the year-to-date period against the Zacks Electronics - Semiconductors industry’s gain of +16.2%. This microcap company with market capitalization of $367.89 million exhibits strong margins in the fiscal first quarter of 2025, with gross margin rising to 86% and operating margin at 65%, driven by a profitable product mix and direct sales.
The company's increased R&D spending by 26%, especially in wafer-level chip scale packaging aimed at medical and industrial applications, expected to drive new revenue streams. Despite a 24% sales decline due to semiconductor downturns, strong cash flows and a $53 million cash reserve support a steady $1.00 per share dividend. NVE Corporation's focus on spintronic technologies positions it well in high-growth sectors.
However, revenue risks persist with heavy reliance on key customers and competitive pressures. Rising operating expenses and labor market challenges may pressure near-term profitability, while supply-chain vulnerabilities and inventory management issues could impact operational efficiency.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Amazon, Roche, GE Aerospace, Canterbury Park and NVE
For Immediate Releases
Chicago, IL – September 9, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN - Free Report) , Roche Holding AG (RHHBY - Free Report) , GE Aerospace (GE - Free Report) , Canterbury Park Holding Corp. (CPHC - Free Report) and NVE Corp. (NVEC - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Amazon.com, Roche and GE Aerospace
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Roche Holding AG and GE Aerospace, as well as two micro-cap stocks Canterbury Park Holding Corp. and NVE Corp. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Amazon.com shares have lost ground lately, along with the rest of its Magnificent 7 peers and other megacap Tech operators, but they have still been strong performers this year (up +13.7% vs. +15.3% for the S&P 500 index. The company is gaining on solid Prime momentum owing to ultrafast delivery services and strong content portfolio. Strengthening relationships with third-party sellers is a positive.
Amazon.com’s expanding global presence and solid momentum among the small and medium businesses, remain a plus. Growing adoption of AWS is aiding Amazon’s cloud dominance. Deepening focus on generative AI is a major plus. Also, improving Alexa skills along with robust smart home products offerings are tailwinds. Growing capabilities in grocery, pharmacy, healthcare and autonomous driving are other positives.
However, macroeconomic challenges remain headwinds. Amazon issued weak third-quarter 2024 revenue guidance due to the changing shopping pattern of consumers, which is a negative.
(You can read the full research report on Amazon.com here >>>)
Shares of Roche have outperformed the Zacks Large Cap Pharmaceuticals industry over the past three months (+22.0% vs. +4.1%). The company's performance in the second quarter and the first half of 2024 was impressive because of the high demand for its drugs and tests.
The second quarter saw an acceleration in growth as total sales were no longer affected by the decline in COVID-19 sales, resulting in very strong sales growth. Consequently, Roche raised its earnings outlook for the full year. Vabysmo, Ocrevus, Evrysdi and Polivy boost growth. Vabysmo has put up a stellar performance against Eylea.
Meanwhile, Roche is also looking to diversify and make inroads in the lucrative obesity market in the wake of declining sales from legacy drugs due to competition from biosimilars. The company’s efforts to develop new drugs are encouraging. The base diagnostics business is also performing well.
(You can read the full research report on Roche here >>>)
Shares of GE Aerospace have outperformed the Zacks Transportation - Airline industry over the past six months (+25.1% vs. +7.7%). The company has been witnessing strength in its businesses, driven by robust demand for commercial engines, propulsion and additive technologies.
Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company. GE Aerospace remains committed to making investments to boost growth and provide better services to its customers.
Its portfolio-reshaping actions are likely to unlock values for its shareholders. Its shareholder-friendly policies are encouraging. For 2024, it expects organic revenues to grow in the high-single-digit range from the year-ago level. However, it has been dealing with high costs and expenses related to projects and restructuring activities.
(You can read the full research report on GE here >>>)
Canterbury Park’s shares have underperformed the Zacks Gaming industry over the year-to-date period (-0.6% vs. +6.8%). This microcap company with market capitalization of $100.78 million offers significant long-term revenue potential through diversified projects like an amphitheater, Winners Circle and residential units, driving growth beyond traditional gaming.
Financially stable with $24 million in cash and short-term investments, Canterbury Park can fund growth without debt. Improved EBITDA margins and diversified revenue streams, including pari-mutuel wagering and event hosting, support CPHC’s earnings stability. The company’s vision of a regional destination is progressing, with leasing success indicating solid demand.
However, risks include a 93.6% drop in second-quarter 2024 net income due to a non-recurring gain in 2023, weak casino revenues and substantial losses from equity investments. Increased competition from nearby casinos could impact market share and profitability.
(You can read the full research report on Canterbury Park here >>>)
Shares of NVE have gained +0.5% over the year-to-date period against the Zacks Electronics - Semiconductors industry’s gain of +16.2%. This microcap company with market capitalization of $367.89 million exhibits strong margins in the fiscal first quarter of 2025, with gross margin rising to 86% and operating margin at 65%, driven by a profitable product mix and direct sales.
The company's increased R&D spending by 26%, especially in wafer-level chip scale packaging aimed at medical and industrial applications, expected to drive new revenue streams. Despite a 24% sales decline due to semiconductor downturns, strong cash flows and a $53 million cash reserve support a steady $1.00 per share dividend. NVE Corporation's focus on spintronic technologies positions it well in high-growth sectors.
However, revenue risks persist with heavy reliance on key customers and competitive pressures. Rising operating expenses and labor market challenges may pressure near-term profitability, while supply-chain vulnerabilities and inventory management issues could impact operational efficiency.
(You can read the full research report on NVE here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.